Metraipolis › archive › dc_8fedaa2cd74b

Evaluating Worldwide Disparities in Bladder Cancer Clinical Trial Availability — Europe PMC PMID:42279313

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42279313
DOI
10.3390/cancers18111730
License (as archived)
solo-consultazione
Archived
2026-11-01T07:19:37.356Z
SHA-256 of the archived text
38af02bbb49eeff243a21f44b88a5816bb5fdccc039fc7a02815a9beccc9b0bd
Stable URL of this page
https://metraipolis.com/documento/dc_8fedaa2cd74b

How to cite

Evaluating Worldwide Disparities in Bladder Cancer Clinical Trial Availability — Europe PMC PMID:42279313 — Europe PMC (en), https://europepmc.org/article/MED/42279313 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8fedaa2cd74b (Metraipolis archive dc_8fedaa2cd74b, sha256 38af02bbb49eeff243a21f44b88a5816bb5fdccc039fc7a02815a9beccc9b0bd)
BibTeX
@misc{dc8fedaa2cd74b,
  title = {Evaluating Worldwide Disparities in Bladder Cancer Clinical Trial Availability — Europe PMC PMID:42279313},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42279313},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8fedaa2cd74b; sha256 38af02bbb49eeff243a21f44b88a5816bb5fdccc039fc7a02815a9beccc9b0bd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42279313. Agents can read the archived copy with the MCP tool read_document.